TNX-1900

N/A

Report date: 2025/11/25 15:39:45

Base Information

Drug NameTNX-1900
Drug Alias NameIntranasal Potentiated Oxytocin鼻内强化催产素TNX-1900
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionOxytocin receptor modulators
TargetsOxytocin receptor
Therapy Area/IndicationsBulimia NervosaBinge-Eating DisorderMigraine without Aura +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTonix Pharmaceuticals Holding Corp
China Registration ClassN/A

Develop Information

Active CompaniesTonix Pharmaceuticals Holding CorpTonix Pharmaceuticals IncMassachusetts General Hospital +[4] 
Inactive CompaniesN/A
Active IndicationsBulimia NervosaBinge-Eating DisorderMigraine without Aura +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A